CYP2C19 genotypes and osteoporotic fractures in long‐term users of proton pump inhibitors: A hospital‐based study
Abstract Proton pump inhibitors (PPIs) are commonly prescribed medications. The existing data suggest that individuals at a high risk of fractures have been exposed to high doses of PPIs for prolonged durations. CYP2C19 plays a pivotal role in metabolism of PPIs and thereby influences their pharmaco...
Saved in:
Main Authors: | Yi‐Ju Liao (Author), Yu‐Ting Chen (Author), Tzu‐Hung Hsiao (Author), Ching‐Heng Lin (Author), Ming‐Fen Wu (Author), Chiann‐Yi Hsu (Author), Yi‐Ming Chen (Author), Chun‐Sheng Hsu (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is hypomagnesemia associated with using proton pump inhibitors?
by: Joo-Hark Yi, et al.
Published: (2016) -
The Effect of Proton Pump Inhibitors on Fracture Formation and Reflection on Care
by: Seda Akutay, et al.
Published: (2021) -
Influence of novel CYP2C‐haplotype on proton pump inhibitor pharmacokinetics in children
by: Kathryn E. Kyler, et al.
Published: (2024) -
Clopidogrel Use and CYP2C19 Genotypes in Patients Undergoing Vascular Intervention Procedure: A Hospital-Based Study
by: Liao YJ, et al.
Published: (2022) -
The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism
by: Nanyong Gao, et al.
Published: (2022)